Clinical Laserthermia Systems AB Class B (CLS.B) Stock Statistics & Valuation Metrics

Clinical Laserthermia Systems AB Class B has a market cap or net worth of €174.53M. The enterprise value is kr53.48M.

Clinical Laserthermia Systems AB Class B has 25,663,593 shares outstanding. The number of shares has decreased by -2.65% in one year.

Clinical Laserthermia Systems AB Class B’s return on equity (ROE) is -0.69 and return on invested capital (ROIC) is -82.32%.

The current PE Ratio of Clinical Laserthermia Systems AB Class B is ―. Clinical Laserthermia Systems AB Class B’s PEG ratio is ―.

In the last 12 months, Clinical Laserthermia Systems AB Class B had revenue of 18.78M and earned -47.62M in profits. Earnings per share was -4.33.

In the last 12 months, operating cash flow was -46.39M and capital expenditures -7.47M, giving a free cash flow of -63.92M billion.

Clinical Laserthermia Systems AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―

Clinical Laserthermia Systems AB Class B upcoming earnings date is Nov 14, 2025, TBA (Confirmed).

Clinical Laserthermia Systems AB Class B as a current ratio of 2.99, with Debt / Equity ratio of 0.33%

In the past 12 months, Clinical Laserthermia Systems AB Class B has paid 0.00 in taxes.

Clinical Laserthermia Systems AB Class B EV to EBITDA ratio is -0.40, with an EV/FCF ratio of -0.28.

Clinical Laserthermia Systems AB Class B has €22.51M in cash and marketable securities with €224.00K in debt, giving a net cash position of -€22.28M billion.

Gross margin is -18.66%, with operating margin of -288.85%, and net profit margin of -253.54%.

The average price target for Clinical Laserthermia Systems AB Class B is €6.56, which is 11.43% higher than the current price. The consensus rating is Hold